Alnylam Pharmaceuticals Stock Forecast
Green day on Friday for Alnylam Pharmaceuticals stock after gaining 1.34%
(Updated on May 03, 2024)
The Alnylam Pharmaceuticals stock price gained 1.34% on the last trading day (Friday, 3rd May 2024), rising from $150.31 to $152.33. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 2.30% from a day low at $151.91 to a day high of $155.41. The price has risen in 6 of the last 10 days and is up by 5.48% over the past 2 weeks. Volume fell on the last day by -199 thousand shares and in total, 440 thousand shares were bought and sold for approximately $67.05 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stockhas broken the wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $149.13, a level that may pose a second chance to hit a runner. According to fan-theory $165.76 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
ALNY Signals & Forecast
The Alnylam Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $147.28 and $149.00. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, April 26, 2024, and so far it has risen 6.29%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. The stock had a Golden Star Signal on Thursday, April 04, 2024 in the short-term chart.
Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.
Golden Star
The stock had a Golden Star Signal on Thursday, April 04, 2024 in the short-term chart.Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.
Support, Risk & Stop-loss for Alnylam Pharmaceuticals stock
Alnylam Pharmaceuticals finds support from accumulated volume at $151.09 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.50 between high and low, or 2.30%. For the last week, the stock has had daily average volatility of 3.75%.
Our recommended stop-loss: $147.13 (-3.41%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 5 days ago.)
Trading Expectations (ALNY) For The Upcoming Trading Day Of Monday 6th
For the upcoming trading day on Monday, 6th we expect Alnylam Pharmaceuticals to open at $153.22, and during the day (based on 14 day Average True Range), to move between $147.86 and $156.80, which gives a possible trading interval of +/-$4.47 (+/-2.93%) up or down from last closing price. If Alnylam Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 5.87% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $151.09 (0.81%) than the resistance at $154.74 (1.58%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Alnylam Pharmaceuticals stock A Buy?
Alnylam Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score: 0.470 Hold/Accumulate Unchanged
Predicted Opening Price for Alnylam Pharmaceuticals of Monday, May 6, 2024
| Fair opening price May 6, 2024 | Current price |
|---|---|
| $153.22 ( 0.582%) | $152.33 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for ALNY
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 156.72 | 2.88 % | |
| R2 | 155.38 | 2.00 % | ||
| R1 | 154.55 | 1.46 % | ||
| Current price: | 152.33 | |||
| Support | S1 | 151.88 | -0.296 % | |
| S2 | 151.05 | -0.84 % | ||
| S3 | 149.72 | -1.72 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 172.18 | 13.03 % | |
| R2 | 157.65 | 3.49 % | ||
| R1 | 154.74 | 1.58 % | ||
| Current price | 152.33 | |||
| Support | S1 | 151.09 | -0.81% | |
| S2 | 147.43 | -3.22% | ||
| S3 | 147.00 | -3.50% |
FAQ
Click here for our free guide on how to buy Alnylam Pharmaceuticals Stock.
